FTC Told DOD Designation Helps Illumina-Grail Deal Appeal
The Federal Trade Commission is considering whether a recent decision by the U.S. Department of Defense designating BGI Genomics as a Chinese military company bolsters attempts by agency staff to revive their challenge...To view the full article, register now.
Already a subscriber? Click here to view full article